Ception Therapeutics, Inc. – Trademark Portfolio

Entity Type: 03

Ception Therapeutics, Inc. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. The owner is based in Malvern, PA.

101 Lindenwood Drive, Suite 400

Malvern, PA 193551769

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EOLOE
EOLOE
Abandoned 2008
EOCEPT
EOCEPT
Abandoned 2008
CINQUIL
CINQUIL
Abandoned 2008
RESLEO
RESLEO
Abandoned 2008
REZLEO
REZLEO
Abandoned 2008
SAREOS
SAREOS
Abandoned 2008
SAREOS
SAREOS
Abandoned 2007
CINQUIL
CINQUIL
Cancelled 2007
EOLOE
EOLOE
Abandoned 2007
EOCEPT
EOCEPT
Abandoned 2007
CEPTION
CEPTION
Cancelled 2006

Trademark Classifications

Ception Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (12 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Ception Therapeutics, Inc. have?

Ception Therapeutics, Inc. has 14 U.S. trademarks filed with the USPTO.

What trademark classes does Ception Therapeutics, Inc. file in?

Ception Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Ception Therapeutics, Inc.'s trademark registration success rate?

Ception Therapeutics, Inc. has a 0% trademark registration rate, with 0 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.